Century Therapeutics, Inc. Revenue 2022–2025
Century Therapeutics, Inc. annual/quarterly revenue history and growth rate from 2022 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Century Therapeutics, Inc. revenue for the quarter ending March 31, 2025 was 109.2 M, a 12667.72% increase year-over-year.
- Century Therapeutics, Inc. revenue for the twelve months ending March 31, 2025 was 111.6 M, a 2562.40% increase year-over-year.
- Century Therapeutics, Inc. annual revenue for 2025 was 109.2 M, a 1556.76% increase from 2024.
- Century Therapeutics, Inc. annual revenue for 2024 was 6.6 M, a 194.81% increase from 2023.
- Century Therapeutics, Inc. annual revenue for 2023 was 2.2 M, a 57.01% decrease from 2022.
- Century Therapeutics, Inc. annual revenue for 2022 was 5.2 M.
Century Therapeutics, Inc. (IPSC) — Frequently Asked Questions
Century Therapeutics, Inc. (IPSC) is a publicly traded US company. It has a market capitalization of $200M. In fiscal 2025 it reported revenue of $109M and net income of -$10M. Explore IPSC's stock price, financial statements, earnings history, margins and key ratios below.
What is Century Therapeutics, Inc.'s market cap?
Century Therapeutics, Inc. (IPSC) has a market capitalization of $200M.
What is the IPSC stock price?
IPSC trades at $2.31 (+8.73% on the day).
How much revenue does Century Therapeutics, Inc. make?
Century Therapeutics, Inc. reported revenue of $109M in fiscal 2025.
Is IPSC profitable?
In fiscal 2025, Century Therapeutics, Inc. reported net income of -$10M.